Mode
Text Size
Log in / Sign up
N/A N=62 Double-blind Treatment

A 6-Hour Clinical Evaluation of New Daily-Wear Soft Contact Lenses

Myopia

Enrolled (actual)
62
Serious AEs
0.0%
Results posted
Oct 2020
Primary outcome: Primary: Horizontal Lens Centration Assessed in Primary Gaze — -0.13; -0.04 millimeters

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Test Lens (Device); Control Lens (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
CooperVision, Inc.
Primary completion
Aug 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Horizontal Lens Centration Assessed in Primary Gaze
-0.15; -0.06
PRIMARY
Horizontal Lens Centration Assessed in Primary Gaze
-0.15; -0.06
PRIMARY
Vertical Lens Centration Assessed in Primary Gaze
0.10; -0.03
PRIMARY
Vertical Lens Centration Assessed in Primary Gaze
0.10; -0.03
PRIMARY
Lens Tightness Assessed by Push-up Test
41; 49
PRIMARY
Lens Tightness Assessed by Push-up Test
41; 49
PRIMARY
Primary Gaze Lag Assessed Observing Lens Movement in Graticule
0.18; 0.12
PRIMARY
Primary Gaze Lag Assessed Observing Lens Movement in Graticule
0.18; 0.12
PRIMARY
Horizontal Lens Lag Assessed Observing Lens Movement in Graticule
3.0; 2.7
PRIMARY
Horizontal Lens Lag Assessed Observing Lens Movement in Graticule
3.0; 2.7
PRIMARY
Overall Lens Fit Acceptance
2.7; 3.0
PRIMARY
Overall Lens Fit Acceptance
2.7; 3.0
PRIMARY
Up Gaze Lag Assessed Observing Lens Movement in Graticule
0.34; 0.35
PRIMARY
Up Gaze Lag Assessed Observing Lens Movement in Graticule
0.34; 0.35
PRIMARY
Post-blink Movement Assessed by Amount of Lens Movement Immediately After the Blink
0.43; 0.29
PRIMARY
Post-blink Movement Assessed by Amount of Lens Movement Immediately After the Blink
0.43; 0.29

Summary

The purpose of this study is to validate the clinical performance of a new contact lens design when worn over a period of 6 hours compared to nelfilcon A (control).

Eligibility Criteria

Inclusion Criteria

  • Is at least 18 years of age and has full legal capacity to volunteer
  • Has read, fully understood and signed the information consent letter
  • Currently wears or has previously worn soft contact lenses
  • Has spectacle cylinder ≤1.00D in both eyes.
  • Has spherical contact lens power requirement between -1.00D and -6.00D in both eyes.
  • Has manifest refraction visual acuities (VA) equal to or better than logMAR equivalent of 20/25 in each eye.
  • Has clear corneas and no active ocular disease
  • Is willing and able to follow product usage instructions and maintain the visit schedule.

Exclusion Criteria

  • Has never worn contact lenses before
  • Has a systemic condition that in the opinion of the investigator may affect a study outcome variable
  • Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable
  • Has any known active ocular disease and/or infection
  • Has a monovision correction
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses
  • Is aphakic
  • Has undergone corneal refractive surgery
  • Is pregnant or lactating, determined by self-report
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03235089). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search